patent/JP-4510021-B2

Predicate	Object
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-553 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D267-14
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D267-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-553 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
filingDate	2004-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate	2010-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate	2010-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	JP-4510021-B2
titleOfInvention	2,3,4,5-Tetrahydrobenzo [F] [1,4] oxazepine-5-carboxylic acid amide derivatives as gamma-secretase inhibitors for the treatment of Alzheimer's disease
priorityDate	2003-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467940778 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID31293 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25496 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID394367

Total number of triples: 22.